CA2259460C - Adenovirus canin de recombinaison (acr) contenant de l'adn exogene - Google Patents

Adenovirus canin de recombinaison (acr) contenant de l'adn exogene Download PDF

Info

Publication number
CA2259460C
CA2259460C CA002259460A CA2259460A CA2259460C CA 2259460 C CA2259460 C CA 2259460C CA 002259460 A CA002259460 A CA 002259460A CA 2259460 A CA2259460 A CA 2259460A CA 2259460 C CA2259460 C CA 2259460C
Authority
CA
Canada
Prior art keywords
cav2
dna
antigen
promoter
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002259460A
Other languages
English (en)
Other versions
CA2259460A1 (fr
Inventor
Laurent Fischer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Animal Health USA Inc
Original Assignee
Merial LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/675,556 external-priority patent/US6156567A/en
Priority claimed from US08/675,566 external-priority patent/US6090393A/en
Application filed by Merial LLC filed Critical Merial LLC
Priority to CA2569241A priority Critical patent/CA2569241C/fr
Priority claimed from PCT/US1997/011486 external-priority patent/WO1998000166A1/fr
Publication of CA2259460A1 publication Critical patent/CA2259460A1/fr
Application granted granted Critical
Publication of CA2259460C publication Critical patent/CA2259460C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
    • C12N2810/60—Vectors comprising as targeting moiety peptide derived from defined protein from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
    • C12N2810/60—Vectors comprising as targeting moiety peptide derived from defined protein from viruses
    • C12N2810/6009—Vectors comprising as targeting moiety peptide derived from defined protein from viruses dsDNA viruses
    • C12N2810/6018—Adenoviridae
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
    • C12N2810/60—Vectors comprising as targeting moiety peptide derived from defined protein from viruses
    • C12N2810/6045—RNA rev transcr viruses
    • C12N2810/6054—Retroviridae
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/60—Vector systems having a special element relevant for transcription from viruses

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA002259460A 1996-07-03 1997-06-30 Adenovirus canin de recombinaison (acr) contenant de l'adn exogene Expired - Lifetime CA2259460C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2569241A CA2569241C (fr) 1996-07-03 1997-06-30 Adenovirus canin de recombinaison (acr) contenant de l'adn exogene

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/675,556 US6156567A (en) 1996-07-03 1996-07-03 Truncated transcriptionally active cytomegalovirus promoters
US08/675,556 1996-07-03
US08/675,566 US6090393A (en) 1996-07-03 1996-07-03 Recombinant canine adenoviruses, method for making and uses thereof
US08/675,566 1996-07-03
PCT/US1997/011486 WO1998000166A1 (fr) 1996-07-03 1997-06-30 ADENOVIRUS CANIN DE RECOMBINAISON (ACR) CONTENANT DE l'ADN EXOGENE

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA2569241A Division CA2569241C (fr) 1996-07-03 1997-06-30 Adenovirus canin de recombinaison (acr) contenant de l'adn exogene

Publications (2)

Publication Number Publication Date
CA2259460A1 CA2259460A1 (fr) 1998-01-08
CA2259460C true CA2259460C (fr) 2007-03-13

Family

ID=38008080

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002259460A Expired - Lifetime CA2259460C (fr) 1996-07-03 1997-06-30 Adenovirus canin de recombinaison (acr) contenant de l'adn exogene

Country Status (1)

Country Link
CA (1) CA2259460C (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3036386A1 (fr) * 2016-09-20 2018-03-29 Boehringer Ingelheim Vetmedica Gmbh Vecteurs d'adenovirus canin

Also Published As

Publication number Publication date
CA2259460A1 (fr) 1998-01-08

Similar Documents

Publication Publication Date Title
AU737243B2 (en) Recombinant canine adenovirus (CAV) containing exogenous DNA
WO1998000166A9 (fr) ADENOVIRUS CANIN DE RECOMBINAISON (ACR) CONTENANT DE l'ADN EXOGENE
JP7187451B2 (ja) アデノウイルスベクター
Prevec et al. A recombinant human adenovirus vaccine against rabies
JP3348156B2 (ja) 組換えアビポックスウィルス
JP2538367B2 (ja) Ｆｏｗｌｐｏｘウィルスの非必須領域
KR0179994B1 (ko) 칠면조의 재조합 포진바이러스 및 이로부터 유도된 생존상태의 벡터 백신
Lüschow et al. Protection of chickens from lethal avian influenza A virus infection by live-virus vaccination with infectious laryngotracheitis virus recombinants expressing the hemagglutinin (H5) gene
Fischer et al. Vaccination of puppies born to immune dams with a canine adenovirus-based vaccine protects against a canine distemper virus challenge
JP2001514518A (ja) 発現の向上したベクター並びにその製造および使用方法
JP2002514885A (ja) ポックスウイルス−イヌジステンパーウイルス（ｃｄｖ）組み換え体類および組成物類および前記組み換え体類を用いる方法
USRE40930E1 (en) Porcine adenovirus type 3 genome
JPH06505874A (ja) 遺伝子操作したワクチン菌株
JPH08500969A (ja) 七面鳥の組換えヘルペスウイルス及びそれらの使用
JP3617668B2 (ja) 麻疹ウイルス組換え体ポックスウイルスワクチン
Fingerut et al. A subunit vaccine against the adenovirus egg-drop syndrome using part of its fiber protein
CA2166371A1 (fr) Vaccin recombinant vivant pour oiseaux, a base de virus herpetique aviaire, actif notamment contre la maladie de gumboro
CN110951778B (zh) 犬瘟热病毒CDV-3株感染性cDNA克隆及其构建方法和应用
US20100008948A1 (en) Recombinant herpesvirus useful in vaccine production
CA2259460C (fr) Adenovirus canin de recombinaison (acr) contenant de l'adn exogene
US5503834A (en) Measles virus recombinant poxvirus vaccine
CA2569241C (fr) Adenovirus canin de recombinaison (acr) contenant de l'adn exogene
AU775125B2 (en) Truncated transcriptionally active cytomegalovirus promoters
US5759841A (en) Immunological composition of measles virus utilizing recombinant poxvirus
AU699903B2 (en) Measles virus recombinant poxvirus vaccine

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20170630